Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–627. (2nd December 2022) - Pham, Codey; Tomcsanyi, Kelly M.; Waljee, Akbar K.; Hou, Jason K.